ReShape Lifesciences Inc. is a developer of minimally invasive medical devices that advance bariatric surgery to treat obesity and metabolic diseases. Our current portfolio includes the LAP-BAND® Adjustable Gastric Banding System and the ReShape VestTM*, an investigational device, to help treat more patients with obesity.
ReShape LifesciencesTM was incorporated in Minnesota in December 2002 under the name Beta Medical, Inc. In 2003, the Company changed its name to EnteroMedics Inc. and in 2004 reincorporated in Delaware. EnteroMedics began trading on the NASDAQ Stock Market on November 15, 2007. The Company acquired ReShape Medical, Inc. in October 2017 and subsequently changed its name to ReShape Lifesciences, Inc. The Company now trades on the OTC under the ticker symbol RSLS.
*Not available for sale in the United States.
Copyright West LLC. Minimum 15 minutes delayed.